Rose Yu
Pulmonary Disease · New York, NYNPI 1184018350
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
How this compares
$0 in reported general payments places this provider in the 5th percentile of 1,115 pulmonary disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 27 | $345,190 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 246 | $244,133 |
| Breo ElliptaFluticasone/Vilanterol | 142 | $77,978 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 48 | $36,071 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 47 | $30,047 |
| Spiriva RespimatTiotropium Bromide | 17 | $20,510 |
| Advair HfaFluticasone Propion/Salmeterol | 39 | $13,063 |
| EliquisApixaban | 16 | $13,040 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $12,012 |
| Arnuity ElliptaFluticasone Furoate | 43 | $10,767 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 73 | $10,462 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 35 | $5,776 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 189 | $4,600 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $4,009 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,000 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in New York
- Linda RogersNew York$7.1M
- Maria PadillaNew York$3.6M
- Juan WisniveskyNew York$3M
- Bushra MinaNew York$2.5M
- Robert KanerNew York$2.3M
- Doreen Addrizzo-HarrisNew York$1.9M
- Emily DimangoNew York$1.4M
- da ZhangNew York$1.3M
- Claire KeatingNew York$1.2M
- Charles PowellNew York$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.